One of the significant challenges is the limited availability of funds compared to the high cost of conducting cutting-edge research. Additionally, securing grants is highly competitive, and not all promising projects receive the necessary financial support. Another issue is the uneven distribution of funds, with some cancer types receiving more attention and resources than others.
